Striatal Activation Predicts Differential Therapeutic Responses to Methylphenidate and Atomoxetine / Schulz, Kurt P. en Journal of the American Academy of Child & Adolescent Psychiatry, Año 2017 - Vol.56 - No.7 ([14/08/2017])

Público ISBD [artículo]  inJournal of the American Academy of Child & Adolescent Psychiatry > Año 2017 - Vol.56 - No.7 [14/08/2017] . - pp.602-609 Título : Striatal Activation Predicts Differential Therapeutic Responses to Methylphenidate and Atomoxetine Tipo de documento: texto impreso Autores: Schulz, Kurt P., Autor ; Bédard, Anne-Claude V., Autor Fecha de publicación: 2017 Artículo en la página: pp.602-609 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Methylphenidate, atomoxetine, caudate nucleus, fMRI, ADHD. Resumen: Methylphenidate has prominent effects in the dopamine-rich striatum that are absent for the selective norepinephrine transporter inhibitor atomoxetine. Link: ./index.php?lvl=notice_display&id=90 [artículo] Striatal Activation Predicts Differential Therapeutic Responses to Methylphenidate and Atomoxetine [texto impreso] / Schulz, Kurt P., Autor ; Bédard, Anne-Claude V., Autor . - 2017 . - pp.602-609. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of the American Academy of Child & Adolescent Psychiatry > Año 2017 - Vol.56 - No.7 [14/08/2017] . - pp.602-609 Palabras clave: Methylphenidate, atomoxetine, caudate nucleus, fMRI, ADHD. Resumen: Methylphenidate has prominent effects in the dopamine-rich striatum that are absent for the selective norepinephrine transporter inhibitor atomoxetine. Link: ./index.php?lvl=notice_display&id=90

---

1 (1 - 1 / 1)